<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25417" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Mycobacterium chelonae Infection</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Akram</surname>
            <given-names>Sami M.</given-names>
          </name>
          <aff>University of Florida, Gainesville</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rathish</surname>
            <given-names>Balram</given-names>
          </name>
          <aff>Guy's and St Thomas' NHS Foundation Trust</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Saleh</surname>
            <given-names>Dahlia</given-names>
          </name>
          <aff>Sampson Regional Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sami Akram declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Balram Rathish declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Dahlia Saleh declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25417.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Mycobacterium chelonae is a nontuberculous mycobacterium (NTM), which is classified as rapidly growing mycobacterium (RGM), class IV in the Runyon classification. M. chelonae is ubiquitous in the environment and has been found in soil, water, and aquatic animals. M. chelonae grows optimally at 30-32 C and may have a long incubation period. It is commonly associated with skin and soft tissue infections, especially infections of the extremities (cellulitis, abscessus). This activity reviews infections caused by M Chelonae and highlights the role of the interprofessional team in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the presentation of M Chelonae infections.</p></list-item><list-item><p>Review the evaluation of a patient the M. Chelonae infection.</p></list-item><list-item><p>Summarize the treatment of M. Chelonae infections.</p></list-item><list-item><p>Explain modalities to improve care coordination among interprofessional team members in order to improve outcomes for patients affected by M. Chelonae.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25417&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25417">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-25417.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p><italic toggle="yes">Mycobacterium chelonae</italic> is a nontuberculous mycobacterium (NTM), which is classified as rapidly growing mycobacterium (RGM), class IV in the Runyon classification. <italic toggle="yes">M. chelonae</italic> was first isolated from a turtle in 1903 by Freidmann, who referred to it as "turtle tubercle bacillus. RGMs account for 50% of known mycobacterial species and are divided into six groups, which are as follows:&#x000a0;<italic toggle="yes">Mycobacterium&#x000a0;</italic><italic toggle="yes">fortuitum</italic> group, <italic toggle="yes">M. chelonae/</italic><italic toggle="yes">Mycobacterium</italic><italic toggle="yes">&#x000a0;abscessus complex,&#x000a0;</italic><italic toggle="yes">Mycobacterium</italic><italic toggle="yes">&#x000a0;smegmatis,&#x000a0;</italic><italic toggle="yes">Mycobacterium</italic><italic toggle="yes">&#x000a0;mucogenicum</italic> group,&#x000a0;<italic toggle="yes">Mycobacterium</italic><italic toggle="yes">&#x000a0;mageritense</italic>/<italic toggle="yes">Mycobacterium</italic><italic toggle="yes">&#x000a0;wolinskyi</italic> and the pigmented RGM.</p>
        <p><italic toggle="yes">M. chelonae</italic> and <italic toggle="yes">M. abscessus</italic> were considered identical until 1992 when <italic toggle="yes">M. chelonae</italic> was elevated to species status. Both <italic toggle="yes">M. chelonae</italic> and <italic toggle="yes">M. abscessus</italic>&#x000a0;have an identical sequence in the 54-510 region but can be differentiated by their intergenic sequence (ITS), <italic toggle="yes">hsp65</italic>, or gene sequences. Susceptibility profiles can be helpful, but they are not ideal in&#x000a0;differentiating between the <italic toggle="yes">M. chelonae</italic> group and M. abscessus group. <italic toggle="yes">M. chelonae group</italic> is characterized by high MICs of cefoxitin (&#x0003e; 64 mg/L) and susceptibility to tobramycin (MIC &#x02264; 4 mg/L), whereas <italic toggle="yes">M. abscessus </italic>shows lower MICs of cefoxitin (&#x02264; 64 mg/L) and resistance to tobramycin (MIC of &#x0003e; 8 mg/L) (3).</p>
        <p><italic toggle="yes">M. chelonae</italic> is ubiquitous in the environment and has been found in soil, water, and aquatic animals. <italic toggle="yes">M. chelonae</italic> grows optimally at 30-32 &#x000b0;C and may have a long incubation period. It is commonly associated with skin and soft tissue&#x000a0;infections, especially infections of the extremities (cellulitis, abscessus). <italic toggle="yes">M chelonae</italic> also causes catheter-related infections and post-surgical infections after implants, transplants, and injections such as sclerotherapy. The eye is second most frequent organ involved. Pulmonary infections are rare when compared to <italic toggle="yes">M. abscessus</italic>. Invasive infections like bacteremia, osteomyelitis, intraabdominal abscess, and disseminated cutaneous infections are common in immunosuppressed patients such as those on steroids, monoclonal antibodies, and post-transplant immunosuppression.&#x000a0;Patients with cancer and or chronic kidney disease are also susceptible to disseminated and invasive disease due to <italic toggle="yes">M. chelonae</italic>.<xref ref-type="bibr" rid="article-25417.r1">[1]</xref><xref ref-type="bibr" rid="article-25417.r2">[2]</xref><xref ref-type="bibr" rid="article-25417.r3">[3]</xref><xref ref-type="bibr" rid="article-25417.r4">[4]</xref></p>
      </sec>
      <sec id="article-25417.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p><italic toggle="yes">M.&#x000a0;chelonae</italic> is a nonmotile, non-spore-forming, gram-positive, acid-fast bacillus. It is a large bacillus with a beaded appearance. <italic toggle="yes">M. chelonae</italic> is a non-chromogen and classified under group IV of Runyon classification. It is grouped in <italic toggle="yes">M.&#x000a0;chelonae/M. abscessus</italic> group among the six groups of rapidly growing mycobacterium. While rapid growers form colonies in seven days, <italic toggle="yes">M.&#x000a0;chelonae</italic> colonies take longer with a mean incubation period of 15 days and may take up to six to eight weeks. <italic toggle="yes">M. chelonae</italic> grows best at 30-32&#x000b0; C. Other mycobacterial in the same group as <italic toggle="yes">M. chelonae</italic> are <italic toggle="yes">M. abscessus</italic> and its three subspecies. Biochemically, <italic toggle="yes">M chelonae</italic> are nitrate negative, do not tolerate 5% NaCl, and fail to turn dark brown when grown on ferric ammonium citrate (iron uptake). <italic toggle="yes">M. chelonae</italic> and <italic toggle="yes">M. abscessus</italic> can be separated biochemically by the utilization of the citrate (4). <italic toggle="yes">M. chelonae</italic> is 100% citrate positive unlike <italic toggle="yes">M. abscessus</italic>, which is 80% citrate negative. <italic toggle="yes">M. chelonae</italic> is catalase positive and oxidase negative. The biochemical methods are inadequate for clinical use. Currently, molecular techniques are frequently used for the diagnosis of atypical mycobacterial infection.<xref ref-type="bibr" rid="article-25417.r5">[5]</xref><xref ref-type="bibr" rid="article-25417.r6">[6]</xref><xref ref-type="bibr" rid="article-25417.r7">[7]</xref></p>
        <p><italic toggle="yes">M. chelonae</italic> is one of the most pathogenic rapidly growing mycobacteria (RGM). In immunocompetent patients, the most common clinical scenario is the localized skin infections, infection after an invasive procedure, or catheter-related infection. Pulmonary infections due to <italic toggle="yes">M. chelonae</italic> are rare, but colonization is common in cystic fibrosis patients. Disseminated and invasive infections are seen in immunocompromised patients. Person to person transmission has not been documented.Cervical lymphadenitis in children can occur but is rare. <italic toggle="yes">Mycobacterium avium intracellulare</italic> and&#x000a0;<italic toggle="yes">Mycobacterium hemophilum</italic> are more frequently associated with cervical lymphadenitis in children compared to <italic toggle="yes">M chelonae</italic>.</p>
      </sec>
      <sec id="article-25417.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p><italic toggle="yes">M. chelonae</italic> and the other RGM are not reportable infections in the United States, and the true prevalence is unknown. Most&#x000a0;Nontuberculous mycobacteria&#x000a0;(NTM) shows increased prevalence in the southern states of Florida, Georgia, Louisiana, and Texas. The national survey done between 1981-1983 evaluating NTM prevalence, showed an annual disease prevalence of 1.78 NTM cases per 100,000 persons, with <italic toggle="yes">M. chelonae/M. abscessus </italic>reported as 0.08 case per 100,000 persons. In a study done in Oregon (2005 to 2006) an annualized prevalence of 7.2 cases per 100,000 persons was reported. In that study, <italic toggle="yes">M chelonae</italic> prevalence was 0.2 cases per 100,000 persons, with the majority causing skin and soft tissue infections. <italic toggle="yes">M. chelonae</italic> cases have been reported globally from the Americas, Eurasia, and Australia, and skin and soft tissues infections remain the most frequent. Overall, there is a trend towards increasing NTM infections worldwide. No age, sex or race predilection has been identified. No seasonal trend has been documented in the <italic toggle="yes">M. chelonae</italic> skin and soft tissue infections. <italic toggle="yes">M. chelonae</italic> have been found in drinking water systems, as the organism is resistant to chlorine. It has been reported more frequently than <italic toggle="yes">M. abscessus</italic> but less than <italic toggle="yes">M. fortuitum or M.&#x000a0;gordanae.</italic>
<italic toggle="yes">M. gordanae</italic> is the most frequently reported mycobacteria found in drinking water systems.[8]</p>
      </sec>
      <sec id="article-25417.s5" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Mycobacterial infections including <italic toggle="yes">M. chelonae</italic> infections can be categorized into several clinical patterns: pulmonary disease, skin and soft tissue infections, musculoskeletal infections, disseminated disease, catheter-associated disease. and lymphadenitis. Skin and soft tissue infections are the most common presentations of <italic toggle="yes">M. chelonae</italic> infections. Infections occur in both immunocompetent and in immunocompromised hosts. <italic toggle="yes">M. chelonae</italic> has a predilection to extremities as it has a tendency to grow at a lower temperature. Nodules, papular rash, and sporotrichoid pattern have been reported. Skin lesions due to <italic toggle="yes">M. chelonae </italic>in the setting of sclerotherapy, acupuncture tattoos, and other injection procedure have been reported. Skin lesions can progress to pustules, hemorrhagic crusts, and abscess formation. <italic toggle="yes">M. chelonae</italic> can also present with Nodular lymphangitis (sporotrichoid lymphocutaneous infections), which is characterized by the development of suppurative inflammatory nodules along lymphatic vessels on the extremities <xref ref-type="bibr" rid="article-25417.r8">[8]</xref>. Disseminated cutaneous disease and advanced skin lesions are common in immunosuppressed patients. Sweet syndrome can be a presenting feature of<italic toggle="yes"> M. chelonae </italic>infection particularly if the skin lesions are on the extremities. Skin lesions mimicking lupus vasculitis can occur due to <italic toggle="yes">M. chelonae </italic>infection. Disseminated disease can present with multiple lesions, complex lesions and in more proximal location. Umbilicated papules, pustules involving the face and upper trunk may be present.</p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">M. chelonae</italic> involving the bone, joints, and muscles has been reported and is common in immunosuppressed patients, deep joint injections, or surgical procedures.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">M. chelonae</italic> can be a contaminant in endoscopes. Catheter-related infections, presenting as fever, sepsis, or disseminated skin lesions due to <italic toggle="yes">M. chelonae</italic> have been described in immunocompromised and pregnant patients.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25417.s6" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Infection with <italic toggle="yes">M.&#x000a0;chelonae</italic> may be asymptomatic. Colonization of the pulmonary tract in cystic fibrosis patients is likely. M. abscessus frequently cause pulmonary infections. Skin biopsy and cultures should help to evaluate skin and subcutaneous infections on the extremities, those not responding to antibiotics, or in patients who had injection procedures or are immunocompromised. The biochemical evaluation in the microbiologic lab is inadequate to identify NTM to the species level, which is important for instituting appropriate therapy. Molecular techniques such as polymerase chain reaction&#x000a0;(PCR) and restriction fragment length polymorphism&#x000a0;(RFLP) should be utilized to identify NTM including <italic toggle="yes">M chelonae.</italic>
<italic toggle="yes">M. chelonae</italic> can have unpredictable resistance pattern. However, most are sensitive to macrolide and aminoglycosides. Susceptibility testing is recommended.</p>
        <p>High-performance liquid chromatography (HPLC) alone is not enough to separate <italic toggle="yes">M. chelonae</italic> from <italic toggle="yes">M. abscessus</italic>. Acridinium ester-labeled DNA probes specific for <italic toggle="yes">M. chelonae</italic> have not been approved. DNA analysis of hypervariable regions A and B cannot differentiate isolates of <italic toggle="yes">M. chelonae</italic> and <italic toggle="yes">M. abscessus</italic>, although they do vary at other 16S rRNA gene sites (only by a total of 4 bp). PRA method currently has been adopted widely for identification of NTM. This system is based on the coupling of the PCR of a heat shock protein (HSP) followed by restriction fragment length identification, which is species specific. Although sufficient to differentiate <italic toggle="yes">M. chelonae</italic> from <italic toggle="yes">M. abscessus</italic> but may not be enough for newer species of NTM.</p>
      </sec>
      <sec id="article-25417.s7" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p><italic toggle="yes">M. chelonae</italic> are uniformly resistant to cefoxitin, imipenem is preferred instead. Tobramycin appears to be more active than amikacin. Isolates are susceptible to tobramycin (100%), clarithromycin (100%), linezolid (90%), imipenem (60%), amikacin (50%), clofazimine, doxycycline (25%), and ciprofloxacin (20%). Clarithromycin monotherapy can be sufficient for localized skin infections. However, there are cases of development of resistance during therapy, which occurs due to a single point mutation at position 2058 of 23S rRNA. For lung disease, disseminated disease and invasive disease with bone and soft tissues involvement, atleast six&#x000a0;months of therapy is recommended with atleast two drugs, including&#x000a0;a macrolide, and a second agent based on susceptibility. Surgical debridement, removal of foreign body, and catheters are an important adjunct to successful therapy. Optimal therapy for lung infection is unknown but most likely similar to other NTM, which results in 12 months of sputum culture negativity. In many published cases of <italic toggle="yes">M. chelonae</italic> infections in immunosuppressed patients, dual therapy with macrolide and amikacin was successful. Corneal infections should be treated with topical agents as well as systemic agents. Treatment should be based on susceptibilities whenever possible. Eye drops containing macrolides, aminoglycosides, and fluoroquinolones are useful.<xref ref-type="bibr" rid="article-25417.r9">[9]</xref><xref ref-type="bibr" rid="article-25417.r10">[10]</xref><xref ref-type="bibr" rid="article-25417.r11">[11]</xref><xref ref-type="bibr" rid="article-25417.r12">[12]</xref><xref ref-type="bibr" rid="article-25417.r11">[11]</xref></p>
      </sec>
      <sec id="article-25417.s8" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Actinomycosis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Blastomycosis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Cryptocosis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Histoplasmosis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Mycetoma</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Mycobacterium abscesses</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Mycobacterium kansasii</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Mycobacterium marinum infection</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Mycobacterium xenopi</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Nocardiosis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25417.s9" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>M. Chelonae can cause infection of almost any organ in the body. The organism is often resistant to many antibiotics and is best managed by an interprofessional team that includes a surgeon, infectious disease specialist, wound care nurse, an internist and an intensivist.&#x000a0;Surgical debridement, removal of foreign body, and catheters are an important adjunct to successful therapy. In many cases, the treatment has to be continued for weeks or months. For patients who are immunocompromised, the prognosis is guarded.<xref ref-type="bibr" rid="article-25417.r13">[13]</xref><xref ref-type="bibr" rid="article-25417.r14">[14]</xref></p>
      </sec>
      <sec id="article-25417.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25417&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25417">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/mycobacterium-chelonae-infection/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=25417">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25417/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25417">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-25417.s11">
        <title>References</title>
        <ref id="article-25417.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jones</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Shier</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Master</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Bao</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>Current significance of the Mycobacterium chelonae-abscessus group.</article-title>
            <source>Diagn Microbiol Infect Dis</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>94</volume>
            <issue>3</issue>
            <fpage>248</fpage>
            <page-range>248-254</page-range>
            <pub-id pub-id-type="pmid">30954313</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25417.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Behra</surname>
                <given-names>PRK</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pettersson</surname>
                <given-names>BMF</given-names>
              </name>
              <name>
                <surname>Shirreff</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>DuCote</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Jacobsson</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Ennis</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Kirsebom</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>Extended insight into the Mycobacterium chelonae-abscessus complex through whole genome sequencing of Mycobacterium salmoniphilum outbreak and Mycobacterium salmoniphilum-like strains.</article-title>
            <source>Sci Rep</source>
            <year>2019</year>
            <month>Mar</month>
            <day>14</day>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>4603</fpage>
            <pub-id pub-id-type="pmid">30872669</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25417.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nakamura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yoshioka</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Miyagawa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yoshikawa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hata</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nakae</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Toda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sawa</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>A case of Mycobacterium chelonae mediastinitis and acute humoral rejection after heart transplantation.</article-title>
            <source>J Card Surg</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>34</volume>
            <issue>4</issue>
            <fpage>205</fpage>
            <page-range>205-207</page-range>
            <pub-id pub-id-type="pmid">30816595</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25417.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Van Landeghem</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Foets</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Desmet</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vanhaecke</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hua</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>Donor-Related Nontuberculous Mycobacterial Interface Infection After Descemet Membrane Endothelial Keratoplasty.</article-title>
            <source>Cornea</source>
            <year>2019</year>
            <month>May</month>
            <volume>38</volume>
            <issue>5</issue>
            <fpage>632</fpage>
            <page-range>632-634</page-range>
            <pub-id pub-id-type="pmid">30747739</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25417.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Padilla</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ly</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dillard</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Boukovalas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zapata-Sirvent</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>LG</given-names>
              </name>
            </person-group>
            <article-title>Medical Tourism and Postoperative Infections: A Systematic Literature Review of Causative Organisms and Empiric Treatment.</article-title>
            <source>Plast Reconstr Surg</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>142</volume>
            <issue>6</issue>
            <fpage>1644</fpage>
            <page-range>1644-1651</page-range>
            <pub-id pub-id-type="pmid">30489537</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25417.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sander</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Isaac-Renton</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Tyrrell</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous Nontuberculous Mycobacterial Infections in Alberta, Canada: An Epidemiologic Study and Review.</article-title>
            <source>J Cutan Med Surg</source>
            <year>2018</year>
            <season>Sep/Oct</season>
            <volume>22</volume>
            <issue>5</issue>
            <fpage>479</fpage>
            <page-range>479-483</page-range>
            <pub-id pub-id-type="pmid">29772918</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25417.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Song</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Nontuberculous mycobacterium infection in renal transplant recipients: a systematic review.</article-title>
            <source>Infect Dis (Lond)</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>50</volume>
            <issue>6</issue>
            <fpage>409</fpage>
            <page-range>409-416</page-range>
            <pub-id pub-id-type="pmid">29400108</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25417.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tirado-S&#x000e1;nchez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bonifaz</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Nodular Lymphangitis (Sporotrichoid Lymphocutaneous Infections). Clues to Differential Diagnosis.</article-title>
            <source>J Fungi (Basel)</source>
            <year>2018</year>
            <month>May</month>
            <day>09</day>
            <volume>4</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">29747448</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25417.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brown-Elliott</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Philley</surname>
                <given-names>JV</given-names>
              </name>
            </person-group>
            <article-title>Rapidly Growing Mycobacteria.</article-title>
            <source>Microbiol Spectr</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>5</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">28084211</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25417.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Banno</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Shield</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sule</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Mycobacteremia from Crushed Hydromorphone Tablet Injection.</article-title>
            <source>Cureus</source>
            <year>2017</year>
            <month>Nov</month>
            <day>27</day>
            <volume>9</volume>
            <issue>11</issue>
            <fpage>e1883</fpage>
            <pub-id pub-id-type="pmid">29387512</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25417.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shah</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Relhan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kuriyan</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Albini</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Pathengay</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Flynn</surname>
                <given-names>HW</given-names>
              </name>
            </person-group>
            <article-title>Endophthalmitis Caused by Nontuberculous Mycobacterium: Clinical Features, Antimicrobial Susceptibilities, and Treatment Outcomes.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>168</volume>
            <fpage>150</fpage>
            <page-range>150-156</page-range>
            <pub-id pub-id-type="pmid">27048999</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25417.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brown-Elliott</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Nash</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>25</volume>
            <issue>3</issue>
            <fpage>545</fpage>
            <page-range>545-82</page-range>
            <pub-id pub-id-type="pmid">22763637</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25417.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Apiwattankul</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Flynn</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Hayden</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Adderson</surname>
                <given-names>EE</given-names>
              </name>
            </person-group>
            <article-title>Infections Caused by Rapidly Growing Mycobacteria spp in Children and Adolescents With Cancer.</article-title>
            <source>J Pediatric Infect Dis Soc</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>4</volume>
            <issue>2</issue>
            <fpage>104</fpage>
            <page-range>104-13</page-range>
            <pub-id pub-id-type="pmid">26407409</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25417.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guglielmetti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mougari</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lopes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Raskine</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cambau</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Human infections due to nontuberculous mycobacteria: the infectious diseases and clinical microbiology specialists' point of view.</article-title>
            <source>Future Microbiol</source>
            <year>2015</year>
            <volume>10</volume>
            <issue>9</issue>
            <fpage>1467</fpage>
            <page-range>1467-83</page-range>
            <pub-id pub-id-type="pmid">26344005</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
